Recent data from our group showed significantly increased MAPK activity, cell proliferation and migration in breast cancer cells stably expressing BRK-Y447F, and decreased migration in breast cancer cells depleted of BRK [28]. This evidence concerns the gene PTK6 and breast carcinoma.